Latest Insider Transactions at Guardant Health, Inc. (GH)
This section provides a real-time view of insider transactions for Guardant Health, Inc. (GH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Guardant Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Guardant Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 12
2020
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
5,000
-55.19%
|
$545,000
$109.37 P/Share
|
|
Oct 12
2020
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+35.56%
|
$25,000
$5.94 P/Share
|
|
Oct 09
2020
|
Svf Bluebird (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,000,000
-49.86%
|
$707,000,000
$101.08 P/Share
|
|
Oct 05
2020
|
Ian T Clark Director |
SELL
Open market or private sale
|
Direct |
2,690
-36.68%
|
$290,520
$108.5 P/Share
|
|
Oct 05
2020
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,690
+26.84%
|
$10,760
$4.18 P/Share
|
|
Sep 25
2020
|
Ian T Clark Director |
SELL
Open market or private sale
|
Direct |
538
-10.38%
|
$57,028
$106.24 P/Share
|
|
Sep 25
2020
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
538
+9.41%
|
$2,152
$4.18 P/Share
|
|
Sep 11
2020
|
John G. Saia Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,491
+18.0%
|
-
|
|
Jun 08
2020
|
Svf Bluebird (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,162,500
-7.65%
|
$96,487,500
$83.16 P/Share
|
|
Jun 04
2020
|
Svf Bluebird (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,750,000
-33.77%
|
$643,250,000
$83.16 P/Share
|
|
Sep 11
2019
|
Svf Bluebird (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,900,000
-17.59%
|
$377,300,000
$77.0 P/Share
|
|
Mar 12
2019
|
Softbank Vision Fund (Aiv M1) L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,033,990
+6.81%
|
$18,305,910
$9.83 P/Share
|
|
Oct 09
2018
|
Soft Bank Group Capital LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,033,990
+50.0%
|
-
|
|
Oct 09
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,534,464
+50.0%
|
-
|
|
Oct 09
2018
|
Tls Beta Pte. Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,613,007
+50.0%
|
-
|
|
Oct 09
2018
|
Softbank Vision Fund (Aiv M1) L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
25,816,470
+50.0%
|
-
|
|
Oct 09
2018
|
Khosla Ventures Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
7,141,498
+50.0%
|
-
|
|
Oct 09
2018
|
Sc Us (Ttgp), Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,768,154
+50.0%
|
-
|